a year ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4425 out of 4426 analysts
Average Return
-20.62%
Win Rate
29%73 out of 256
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-07 - 2020-09-14 | Buy |
Turning Point Therapeutics IncTPTX | +208.74% | $35.13 | $108.46 | 2020-03-17 - 2021-03-17 | Buy |
Immunomedics IncIMMU | +158.98% | $32.30 | $83.65 | 2020-05-07 - 2020-09-14 | Buy |
Turning Point Therapeutics IncTPTX | +153.91% | $29.44 | $74.75 | 2022-03-22 - 2022-06-06 | Buy |
Tango Therapeutics IncTNGX | +144.15% | $3.76 | $9.18 | 2023-03-28 - 2023-12-08 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Igm Biosciences IncIGMS | 9 | Hold | $7.00 | +5.26% | Downgrades | 3 days ago |
Portage Biotech IncPRTG | 5 | Buy | $6.00 | +426.32% | Maintains | 11 days ago |
Springworks Therapeutics IncSWTX | 19 | Buy | $73.00 | +131.75% | Maintains | 11 days ago |
Biontech SeBNTX | 19 | Buy | $133.00 | +28.59% | Reiterates | 13 days ago |
Kronos Bio IncKRON | 6 | Buy | $9.00 | +538.30% | Reiterates | 13 days ago |
Calidi Biotherapeutics IncCLDI | 1 | Buy | $11.00 | +416.43% | Initiates Coverage On | 18 days ago |
Black Diamond Therapeutics IncBDTX | 4 | Buy | $11.00 | +266.67% | Reiterates | 18 days ago |
Nuvation Bio IncNUVB | 5 | Buy | $4.50 | +238.35% | Reiterates | 18 days ago |
Adc Therapeutics SaADCT | 11 | Buy | $3.00 | +194.12% | Maintains | 20 days ago |
Repare Therapeutics IncRPTX | 8 | Buy | $25.00 | +293.70% | Reiterates | 20 days ago |
Allogene Therapeutics IncALLO | 7 | Buy | $12.00 | +385.83% | Maintains | 25 days ago |
Y Mabs Therapeutics IncYMAB | 7 | Buy | $11.00 | +55.37% | Reiterates | 25 days ago |
Effector Therapeutics IncEFTR | 2 | Buy | $5.00 | +863.39% | Reiterates | a month ago |
Revolution Medicines IncRVMD | 10 | Buy | $28.00 | +13.87% | Maintains | a month ago |
Aadi Bioscience IncAADI | 9 | Buy | $36.00 | +625.81% | Maintains | a month ago |
Replimune Group IncREPL | 8 | Buy | $48.00 | +558.44% | Maintains | a month ago |
Macrogenics IncMGNX | 10 | Buy | $12.00 | +37.77% | Maintains | a month ago |
Omega Therapeutics IncOMGA | 6 | Buy | $12.00 | +424.02% | Maintains | a month ago |
Relay Therapeutics IncRLAY | 11 | Buy | $19.00 | +102.77% | Maintains | a month ago |
Prelude Therapeutics IncPRLD | 7 | Buy | $5.00 | +48.81% | Maintains | a month ago |
Elicio Therapeutics IncELTX | 1 | Buy | $12.00 | +100.33% | Assumes | a month ago |
Oric Pharmaceuticals IncORIC | 11 | Buy | $16.00 | +69.67% | Maintains | a month ago |
Pmv Pharmaceuticals IncPMVP | 6 | Buy | $5.00 | +116.45% | Maintains | 2 months ago |
Apollomics IncAPLM | 3 | Buy | $17.00 | +1,935.93% | Maintains | 2 months ago |
Exelixis IncEXEL | 1 | Buy | $28.00 | +27.27% | Initiates Coverage On | 2 months ago |
Nurix Therapeutics IncNRIX | 9 | Buy | $35.00 | +306.98% | Maintains | 3 months ago |
Cogent Biosciences IncCOGT | 3 | Buy | $27.00 | +212.50% | Reiterates | 3 months ago |
Kineta IncKA | 3 | Buy | $8.00 | +86.48% | Reiterates | 4 months ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | +948.03% | Reiterates | 4 months ago |
Zymeworks IncZYME | 11 | Hold | $8.00 | -13.89% | Reiterates | 4 months ago |
Viracta Therapeutics IncVIRX | 5 | Buy | $10.00 | +1,896.01% | Reiterates | 4 months ago |
Tango Therapeutics IncTNGX | 4 | Buy | $16.00 | +74.29% | Maintains | 4 months ago |
Gt Biopharma IncGTBP | 6 | Buy | $5.00 | +2,122.22% | Reiterates | 4 months ago |
Caribou Biosciences IncCRBU | 5 | Buy | $23.00 | +295.87% | Maintains | 4 months ago |
Atara Biotherapeutics IncATRA | 5 | Buy | $28.00 | +4,079.10% | Maintains | 6 months ago |
Ikena Oncology IncIKNA | 4 | Buy | $22.00 | +1,057.89% | Reiterates | 9 months ago |
Fate Therapeutics IncFATE | 6 | Hold | $7.00 | +212.50% | Downgrades | a year ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | a year ago |
Neoleukin Therapeutics IncNLTX | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | a year ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 2 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Nucana PLCNCNA | 2 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 2 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.